David V. Goeddel, Director, 10% Owner at Tenaya Therapeutics, Inc. (TNYA), bought 1,500,000 shares at $2.60 ($3.9M) on 2023-02-08, disclosed to the SEC on 2023-02-10.
Open-market purchase of $3.9M TNYA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| NGM | BUY | 2023-02-01 | $921K | — | Filing → |